Search Result "Istradefylline"
A2A Adenosine Receptor Antagonists as Therapeutic Candidates: Are They Still an Interesting Challenge?
Journal: Mini-Reviews in Medicinal Chemistry
Volume: 18 Issue: 14 Year: 2018 Page: 1168-1174
Author(s): Barbara Cacciari,Giampiero Spalluto,Stephanie Federico
Role of Adenosine Receptors in Rare Neurodegenerative Diseases withMotor Symptoms
Journal: Current Protein & Peptide Science
Volume: 22 Issue: 9 Year: 2021 Page: 675-694
Author(s): Vicent Beltran-Beltran,Noelia Benetó,Tamara Lapeña-Luzón,Laura R. RodrÃguez,Federico V. Pallardó,Pilar Gonzalez-Cabo
A2A Adenosine Receptor Antagonists and their Potential in NeurologicalDisorders
Journal: Current Medicinal Chemistry
Volume: 29 Issue: 28 Year: 2022 Page: 4780-4795
Author(s):
Overview of Therapeutic Drugs and Methods for the Treatment of Parkinsonâs Disease
Journal: CNS & Neurological Disorders - Drug Targets
Volume: 19 Issue: 3 Year: 2020 Page: 195-206
Author(s): Andrew Schneider,Adam T. Sari,Hasan Alhaddad,Youssef Sari
An Update on Adenosine A2A Receptors as Drug Target in Parkinsons Disease
Journal: CNS & Neurological Disorders - Drug Targets
Volume: 10 Issue: 6 Year: 2011 Page: 659-669
Author(s):
Blocking Striatal Adenosine A2A Receptors: A New Strategy for Basal Ganglia Disorders
Journal: Recent Patents on CNS Drug Discovery (Discontinued)
Volume: 2 Issue: 1 Year: 2007 Page: 1-21
Author(s): Christa E. Muller, Sergi Ferre
Natural Products of Dietary Origin as Lead Compounds in Virtual Screening and Drug Design
Journal: Current Pharmaceutical Biotechnology
Volume: 13 Issue: 1 Year: 2012 Page: 117-124
Author(s): Werner J. Geldenhuys, Anupam Bishayee, Altaf S. Darvesh, Richard T. Carroll
An Update on Nondopaminergic Treatments for Motor and Non-motorSymptoms of Parkinsonâs Disease
Journal: Current Neuropharmacology
Volume: 21 Issue: 8 Year: 2023 Page: 1806-1826
Author(s):
Blocking Striatal Adenosine A2A Receptors: A New Strategy for Basal Ganglia Disorders
Ebook: Frontiers in CNS Drug Discovery
Volume: 1 Year: 2010
Author(s): Christa E. Muller, Sergi Ferre
Doi: 10.2174/978160805159511001010304
Editorial [Pharmacology and Therapeutic Activity of Purinergic Drugs for Disorders of the Nervous System]
Journal: CNS & Neurological Disorders - Drug Targets
Volume: 11 Issue: 6 Year: 2012 Page: 649-651
Author(s): G. Burnstock,C. Volonte